Regina E. Groves

CIK: 0001653877

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ATRC

AtriCure, Inc.

Director

FLGT

Fulgent Genetics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ATRC
AtriCure, Inc.
Sep 11, 2026
Sale(S)
Direct
5.3K shares at avg. $54.22$288K
ATRC
AtriCure, Inc.
May 18, 2026
Award(A)
Direct
6.1K shares-
FLGT
Fulgent Genetics, Inc.
May 14, 2026
Award(A)
Direct
11.1K shares-
ATRC
AtriCure, Inc.
Aug 6, 2025
Sale(S)
Direct
2.5K shares at avg. $36.82$90K
ATRC
AtriCure, Inc.
May 19, 2025
Award(A)
Direct
5.4K shares-
FLGT
Fulgent Genetics, Inc.
May 15, 2025
Award(A)
Direct
9K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	ATRC AtriCure, Inc.	Sale(S)	5,313	$54.22	$288,071	Direct
May 18, 2026	ATRC AtriCure, Inc.	Award(A)	6,144	-	$0	Direct
May 14, 2026	FLGT Fulgent Genetics, Inc.	Award(A)	11,117	-	$0	Direct
Aug 6, 2025	ATRC AtriCure, Inc.	Sale(S)	2,452	$36.82	$90,283	Direct
May 19, 2025	ATRC AtriCure, Inc.	Award(A)	5,401	-	-	Direct
May 15, 2025	FLGT Fulgent Genetics, Inc.	Award(A)	8,982	-	-	Direct

1-6 of 6 transactions

About GROVES REGINA E

GROVES REGINA E (SEC CIK 0001653877) files insider reports with the SEC as Director of AtriCure, Inc. (ATRC) and Director of Fulgent Genetics, Inc. (FLGT).

Signal8 holds 6 ownership filings by GROVES REGINA E, all Form 4s, filed between May 19, 2025 and Sep 14, 2026. Those filings report 6 transactions, from May 15, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GROVES REGINA E's filings is in MASON, OH.

Recent filings by GROVES REGINA E

Sep 11, 2026: Open-market sale of ATRC shares (Form 4, code S).
May 18, 2026: Grant or award of ATRC shares (Form 4, code A).
May 14, 2026: Grant or award of FLGT shares (Form 4, code A).
Aug 6, 2025: Open-market sale of ATRC shares (Form 4, code S).
May 19, 2025: Grant or award of ATRC shares (Form 4, code A).

Other insiders filing for AtriCure, Inc. (ATRC)

Privitera Salvatore, Chief Technical Officer
Dahlquist Karl S., Chief Legal Officer
Prange Karen, Director
Yuen Maggie, Director
CARREL MICHAEL H, President, CEO, & Director
Doraiswamy Vinayak, Chief Scientific Officer

How to read Form 4 transaction codes